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Bacteria have the ability to change their lifestyle to adapt to various environmental conditions. 
Cyclic dinucleotides (cDNs) are ubiquitous second messengers that can regulate fundamental 
lifestyle switches, such as motility versus sessility and acute versus chronic virulence, in 
bacteria. Investigation of the diverse established cDNs, cyclic di-GMP, cyclic di-AMP, and the 
recently identified hybrid molecule cyclic GAMP, expanded our knowledge of the complexity 
of regulation of bacterial physiology by nucleotide-based second messengers and unravel 
common and distinct regulatory patterns. 
In this thesis, we provided the molecular basis to assess the regulatory mechanisms of semi-
constitutive rdar biofilm formation by Illumina Miseq or PacBio sequencing of the genomes of 
eight rdar biofilm forming E. coli strains (Paper I). By using phenotypic, genetic and 
biochemical approaches, we showed that animal commensal isolate E. coli ECOR31 expresses 
a semi-constitutive rdar biofilm morphotype on agar plates characterized by expression of the 
extracellular matrix components cellulose and curli fimbriae. This morphotype is 
conventionally dependent on the major biofilm regulator CsgD and positively regulated by 
cyclic di-GMP signaling (Paper II). As expected, flagella-dependent motility is negatively 
regulated by cyclic di-GMP signaling. Bioinformatic analysis suggested the presence of a 
dinucleotide cyclase DncV homolog, hypothesized to possess cyclic GAMP synthase activity, 
encoded by the E. coli ECOR31 genome. DncV synthesized 3’3’-cGAMP in vitro and in vivo 
and, via its catalytic activity, negatively regulated csgD expression at the transcriptional level 
with subsequent suppression of rdar biofilm formation and cell aggregation. DncV also 
suppressed swimming and swarming motility post-transcriptional of class 1 flagellar regulon 
genes. In liquid culture, expression of dncV restricted cell aggregation, but showed a complex 
temporal pattern of biofilm formation at the abiotic surface.  
The patatin-like phospholipase CapV is a receptor for 3’3’-cGAMP. In this thesis, we showed 
that expression of CapVQ329R, a single amino acid variant of CapV, induced extensive cell 
filamentation in E. coli MG1655 independently of the 3’3’-cGAMP synthase DncV (Paper 
III). Moreover, overexpression of CapVQ329R repressed swimming motility by inhibiting 
flagella biosynthesis and reduced rdar biofilm formation and CsgD expression, possibly 
through modulation of cyclic di-GMP levels. The observed phenotypes of CapVQ329R are not 
restricted to E. coli MG1655, but common to other E. coli strains and S. typhimurium UMR1 
suggesting that conserved pathway(s) are required for their expression.  
Based on our genome sequences, in the last study, we investigated the molecular basis of 
temperature-independent expression of the rdar biofilm morphotype and subsequently csgD 
expression in seven semi-constitutive rdar biofilm forming E. coli strains (Paper IV). Based 
on the observation that amino acid variations in cyclic di-GMP turnover proteins correlated 
with the expression of a semi-constitutive rdar biofilm, in particular, we demonstrated that 
distinct amino acid changes outside of conserved signature motifs that potentially lead to an 
alteration in the trigger activity of the hybrid cyclic di-GMP phosphodiesterase/diguanylate 
 
 
cyclase YciR contributed to regulate rdar biofilm formation and csgD expression in semi-
constitutive rdar biofilm forming E. coli strains. 
In conclusion, this thesis highlights that diverse cDN second messenger signals differentially 
regulate the bacterial sessile/motile lifestyle transition. Furthermore, the effect of CapVQ329R 
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1 INTRODUCTION 
The capability of bacteria to sense and respond to environmental signals is vital for survival. 
Bacteria use nucleotide-based molecules as second messengers to regulate various modes of 
physiological processes in response to a first signal, which can be an environmental signal such 
as divers nutrients, various stress signals, temperature, osmolarity, pH, light, and quorum 
sensing (1, 2). Cyclic dinucleotides (cDNs) act as intracellular second messengers that amplify 
the signal, thereby distinctively modulating bacterial physiology to regulate, for example, the 
fundamental lifestyle transition between motility and sessility (biofilm formation) on the 
transcriptional to the post-translational level (3). Four major cDNs have been discovered up to 
now: cyclic dimeric guanosine monophosphate (c-di-GMP), cyclic dimeric adenosine 
monophosphate (c-di-AMP), and the hybrid cyclic guanosine monophosphate-adenosine 
monophosphate (cGAMP), which exists as a canonical and non-canonical structural analog. 
3’3’-cGAMP occurs in bacteria, while 2’3’-cGAMP has been identified as a major innate 
immunoregulator in eukaryotes (1, 2, 4). Cyclic di-GMP has been recognized as a key regulator 
of the bacterial sessility/motility lifestyle switch in all Gram-negative and Gram-positive 
bacteria where it has been investigated (2, 5-7). On the other hand, c-di-AMP is involved in 
physiological functions such as the monitoring of DNA integrity, osmoprotection, cell-wall 
synthesis, potassium homeostasis and virulence mainly in Gram-positive bacteria and 
Mycobacteria (8). Cyclic GAMP was first identified in Vibrio cholerae O1 biovar El Tor 7th 
pandemic strains as a signaling molecule involved in chemotaxis and virulence (4). In 
eukaryotes, all of these cDNs, besides the intrinsic signaling molecule 2’3’-cGAMP, are 
recognized as important pathogen- or microbial-associated molecular patterns (PAMPs or 
MAMPs) that trigger a distinct innate immune response (9). 
1.1 CYCLIC DI-GMP 
The bacterial second messenger cyclic di-GMP (c-di-GMP) was firstly discovered by Moshe 
Benziman and his colleagues in 1987 as an allosteric activator of the bacterial cellulose 
synthase in the Gram-negative fruit-degrading bacterium Komagataeibacter 
(Gluconacetobacter) xylinus, previously known as Acetobacter xylinum (10). More than fifteen 
years after this seminal discovery, c-di-GMP has been established as a ubiquitous bacterial 
second messenger involved in the regulation of complex lifestyle changes, such as the transition 
between sessility and motility, cell cycle regulation, the transition between acute and chronic 
virulence and various additional associated phenotypes in bacteria (2, 5, 6) (Figure 1). Cyclic 
di-GMP has been primarily investigated in Gram-negative bacteria, including Escherichia coli, 
Salmonella typhimurium, Pseudomonas aeruginosa, Caulobacter crescentus, Klebsiella 
pneumoniae, Legionella pneumophila, Yersinia pestis and Vibrio cholerae, and a few Gram-
positive bacteria, such as Bacillus subtilis, Streptomyces spp., Staphylococcus aureus, 
Clostridium difficile and Listeria monocytogenes, but not in archaea (5, 11).  
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Figure 1 Overview of the c-di-GMP signaling network in bacteria. Cyclic di-GMP is 
synthesized by DGCs with a GGDEF domain and hydrolyzed by PDEs with an EAL or HD-
GYP domain. Cyclic di-GMP is sensed by protein or RNA receptors, including PilZ domain 
receptors, I-site receptors, inactive EAL or HD-GYP domain receptors, MshEN domain 
receptors, divers transcriptional regulators e.g. FleQ and VpsT, and riboswitches e.g. c-di-GMP 
binding GEMM-I and GEMM-II riboswitches. The diagram shows the protein domains 
involved in c-di-GMP turnover and signaling. Enzymatically active and inactive GGDEF, EAL, 
and HD-GYP domains are indicated by light pink and pink, respectively.  
1.1.1 C-di-GMP mediated physiological functions 
In nature, most microorganisms exist primarily in larger communities rather than single 
planktonic cells whereby they can attach to a biotic or abiotic surface and subsequently build 
up single and multispecies cell aggregates to accumulate at interfaces (12). The 
ubiquituousness and predominance of biofilm formation in almost any environment with an 
adequate combination of moisture, carbon and energy provision covers plant and body tissues, 
natural materials, metals, plastics, medical implant materials and natural environments with 
even extreme conditions such as host springs and alkaline hydrothermal vents (13, 14). In 
clinical settings, biofilms are a major cause of persistent human infections. Such arrangement 
into multicellular communities (biofilm formation) is possible through the production of 
extracellular polymeric substances (EPS), which is similar to tissue formation in higher 
organisms (15) (Figure 2). A microbial biofilm is mainly comprised of EPS (approx. 85% dry 
biomass), which provides a physical and chemical protection from adverse growth conditions 
and environmental threats, such as desiccation, phages (bacteria-attacking viruses), 
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Figure 2 Schematic illustration of subsequent developmental stages leading to biofilm 
formation. Biofilm formation is initiated with the reversible attachment of a single planktonic 
cell followed by surface scanning using surface appendages such as type IV pili (P. aeruginosa) 
or type I pili (E. coli) and subsequent adhesion to the surface by extracellular matrix 
components such as cellulose (S. typhimurium) (16) (stage 1). The bacteria then form a 
monolayer and irreversibly attach by producing an extracellular matrix (stage 2). Next, a 
microcolony is formed where multilayers appear (stage 3). During later stages, a mature biofilm 
is developed, which can display as a characteristic mushroom or slime-like structure due to 
EPS production (stage 4). Eventually, some cells start to detach and the biofilm will disperse 
(stage 5). The figure is adapted from a figure originated from Annika Cimdins-Ahne. 
Cyclic di-GMP has been shown to regulate multiple modes of biofilms formation. Model 
system biofilms demonstrated to be c-di-GMP regulated include pellicle formation at the air 
liquid interface, rdar (red, dry and rough) or rugose morphotype formation on agar plates, 
adhesion to abiotic surfaces, cell aggregates and biofilm formation in continuous flow systems 
(17). Consecutively, the distinct expression of a multitude of combinatorial extracellular matrix 
components including exopolysaccharides, adhesive pili, non-fimbrial adhesins as well as 
extracellular DNA is affected by c-di-GMP signaling (2, 18). In Enterobacteriaceae, c-di-GMP 
regulates a distinct multicellular behavior termed the rdar morphotype. Thereby, c-di-GMP 
promotes the expression of the transcriptional regulator CsgD, which subsequently activates 
production the extracellular biofilm components the exopolysaccharide cellulose and amyloid 
curli fimbriae in S. typhimurium and E. coli (2, 18). The rdar morphotype (Figure 3), a well-
established validated biofilm model, is visualized on agar plates containing Congo Red and 
Coomassie Brilliant Blue, which differentially binds to the extracellular matrix components 
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Figure 3 The rdar morphotype of E. coli ECOR31 after 3 days of growth on a Congo Red agar 
plate. 
Transition from motility to sessility is an important universal switch regulated by c-di-GMP. 
Motility, which is defined as the ability to actively move, is a major survival mechanism of 
most microorganisms (19). For example, P. aeruginosa, E. coli, and other bacteria can move 
on surfaces by the extension and retraction of type IV pili in a process called twitching motility 
(20). A very common mode of motility which many bacteria exhibit is motility mediated by 
propelling of flagella; in peritrichously flagellated E. coli up to 10 μm long and 20 nm wide 
appendages. Two forms of flagella mediated motility have been described: swimming motility 
in liquid or semi solid medium and the swarming motility on the surface of semi-solid medium 
(19, 21). In contrast to biofilm formation, flagellum-based swimming and swarming motility 
in E. coli and S. typhimurium is inhibited by c-di-GMP on the post-transcriptional level (21). 
Cyclic di-GMP binds to the PilZ domain protein YcgR, which interacts with FliG and FliM, 
the subunits of the flagella switch complex to induce a counterclockwise (CCW) rotational bias 
and slow down the flagellar motor rotation. As a consequence, smooth swimming for a longer 
time with fewer frequencies of tumbling intervals is achieved (22-24). According to another 
proposed model, c-di-GMP bound YcgR directly interacts with MotA, the stator component of 
the flagella motor thereby reducing the rotation speed of the motor (25). Moreover, c-di-GMP 
can also bind FliI, the flagella export AAA+ ATPase, to repress swimming motility (26). In 
other bacteria, in addition to posttranslational regulation of motility, c-di-GMP regulates 
motility at the transcriptional level. For example, in V. cholerae, the transcription factor VpsT 
requires c-di-GMP to be active and to suppress flagellar gene expression (27). 
Cyclic di-GMP also contributes to cell cycle progression and alterations in cell morphology in 
the aquatic bacterium Caulobacter crescentus (28, 29). C. crescentus undergoes asymmetric 
cell division, which generates a motile and replication-inert swarmer cell and a sessile and 
replication-competent stalked cell. The transition from a motile to a sessile state of C. 
crescentus is coordinated by c-di-GMP through its metabolizing proteins. Specifically, the 
diguanylate cyclase (DGC) PleD, which is inactive in swarmer cells, is activated upon 
phosphorylation and localizes to the stalked cell pole to control flagella ejection and 
subsequently biogenesis of stalk and holdfast (30, 31). Localization of phosphorylated PleD 
helps to recruit PopA, a c-di-GMP effector protein that binds c-di-GMP through its I-site, 
sequesters to the stalked cell pole and helps to recruit the replication initiation inhibitor CtrA 
via the mediator protein RcdA to be delivered and degraded by the polar protease ClpXP (32-
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34). DgcB is another DGC involved in C. crescentus holdfast biogenesis and surface 
attachment. DgcB inhibits motility by counteracting the c-di-GMP phosphodiesterase (PDE) 
PdeA to lower c-di-GMP level in the swarmer cell (35). Also, in other bacteria, c-di-GMP 
contributes to alterations in cell morphology and regulation of the cell cycle (36, 37). In 
Mycobacterium smegmatis, c-di-GMP signaling is not only required for the maintenance of 
proper growth under stress conditions, but also affects the cell size and cell division (37). YfiN, 
a bifunctional DGC in E. coli, blocks cell division through preventing the initiation of septal 
peptidoglycan synthesis in response to envelope stress (36). 
Besides, c-di-GMP also regulates other physiological processes in bacteria, such as survival 
and transmission of the obligate intracellular pathogen Borrelia burgdorferi in insect and 
mammalian hosts, photosynthesis and heterocyst formation in Cyanobacteria, multicellular 
development, sporulation and antibiotic production in Streptomycetes, long-term survival and 
lipid metabolism and transport in Mycobacteria, the type III secretion system in S. typhimurium, 
P. aeruginosa and other bacteria and antioxidant regulation in M. smegmatis (38-42).  
1.1.2 C-di-GMP metabolism 
Diguanylate cyclases (DGCs), the enzymes that perform c-di-GMP synthesis, are structurally 
similar to type III nucleotidyl transferases and adenylate cyclases, but contain a unique 
conserved GGDEF signature motif (2, 43). GGDEF domain proteins function as homodimers, 
whereby each monomer contributes one bound GTP molecule to form the phosphodiester 
bonds. In the majority of cases, one of the two divalent metal ions Mg2+ and Mn2+ is required 
for phosphodiester bond formation between two GTP molecules to form 5’-pppGpG, an 
intermediate product that is converted into c-di-GMP with the release of two inorganically 
phosphate molecules (1, 2). The first two glycine residues of the central GGDEF motif are 
involved in GTP binding whereas the fourth amino acid glutamate is involved in metal ion 
coordination. The third residue which can be aspartate or glutamate is required for catalysis 
and metal ion coordination (44). The RxxD motif is located five amino acids upstream of the 
GGDEF motif. Upon c-di-GMP binding to the RxxD motif, DGC activity of the GGFEF 
domain is inhibited. The RxxD motif, an essential part of this c-di-GMP binding site, is 
conserved in approximately half of the GGDEF domain proteins and also named “I site” 
(inhibitory site) due to its allosteric inhibitory function, is required to potentially restrict the 
signal (2, 44, 45). However, the function of the I-site extends beyond the allosteric regulation 
of enzymatic activity (46, 47). 
The hydrolysis of c-di-GMP is achieved by two major groups of phosphodiesterases (PDEs): 
HD-GYP and EAL domain PDEs. Cyclic di-GMP PDEs with HD-GYP domain hydrolyze c-
di-GMP to two GMP molecules, while PDEs with EAL domain cleave c-di-GMP into a linear 
5’-pGpG that is further hydrolyzed into two GMP molecules by HD-GYP domain PDEs or 
oligoribonucleases (2, 48-51). Metal ions, Mg2+, Fe3+, or Mn2+ are coordinated for catalysis by 
both HD-GYP and EAL domain PDEs, with Ca2+ to strongly inhibit the PDE enzymatic activity 
of the EAL domain (2, 52, 53). Conserved signature motifs of EAL domains extend beyond 
the conserved EAL motif (51, 54). The first glutamate residue of the EGVE motif of the EAL 
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domain serves as a general base catalyst, which accepts the proton from a water molecule. The 
produced hydroxide ion subsequently conducts the nucleophilic attack, resulting in the 
weakening and subsequent hydrolysis of the phosphoester bond (55). In addition, the conserved 
DFG(T/A)GYSS motif of the loop 6 of the EAL domain which connects elements of secondary 
structure, a β-sheet and an α-helix is essential for catalytic activity (54, 56). Structural studies 
showed that c-di-GMP in the EAL domains is present in an extended (open) conformation 
which facilitates hydrolysis of one of the phosphodiester bonds in c-di-GMP. In contrast, c-di-
GMP in HD-GYP domains is revealed as a bent, U-shaped (closed) conformation as observed 
in the I sites of DGCs and some PilZ domain c-di-GMP receptors (2, 57, 58). Besides HD-GYP 
domain PDEs and EAL domain PDEs, some proteins with DHH–DHHA1 motifs (signature 
motif for c-di-AMP hydrolysis) can also hydrolyze c-di-GMP, e.g. Rv2837c from M. 
tuberculosis specifically targets the 3’5’ phosphodiester bond and degrades c-di-GMP to GMP 
(59, 60). 
GGDEF/EAL/HD-GYP domains belong to abundant bacterial protein superfamilies. The 
number of GGDEF/EAL/HD-GYP domain proteins can, though, vary dramatically within a 
genus even between closely related bacterial species (11, 61). Genomic analyses showed that 
a GGDEF domain is often coupled to an EAL domain or a HD-GYP domain. For example, the 
S. typhimurium genome encodes twenty-one GGDEF/EAL domain proteins, of which five 
proteins contain a GGDEF, nine an EAL domain and seven contain both a GGDEF and an 
EAL domain (18, 62). The genome of the laboratory model organism E. coli K-12 strains 
contains twenty-nine GGDEF/EAL domain proteins, including twelve proteins with a GGDEF 
domain, ten proteins with an EAL domain and seven proteins with both a GGDEF and an EAL 
domain (63). Although less investigated than GGDEF-EAL domain proteins, GGDEF-HD-
GYP domain proteins are also widespread in bacteria, particularly among the Aquificae, 
Deinococci, Firmicutes and Planctomycetes (2). Typically, in such protein tandems one of the 
two domains is enzymatically inactive, but bifunctional DGCs/PDEs exist. For example, the 
BphG1 protein from Rhodobacter sphaeroides, a bacteriophytochrome with a PAS-GAF-PHY 
photosensory module followed by a GGDEF-EAL output domain (64), the PAS-GGDEF-EAL 
domain protein PP2258 from Pseudomonas putida (65) and the STM1703/YciR from S. 
typhimurium (66), possess both, DGC and PDE, activities. However, for example, YciR, which 
has homologs in species outside of the gamma-proteobacteria in the phylogenetic tree, 
regulates rdar morphotype and csgD expression independently of the catalytic activities 
through protein-protein interactions (66-68). 
1.1.3 C-di-GMP receptors 
Many different types of c-di-GMP binding proteins (receptors) with different binding sites have 
been identified in bacteria so far: PilZ domain receptors, DGC I-site receptors, catalytically 
inactive EAL and HD-GYP domain receptors, MshEN domain receptors, and other c-di-GMP 
receptors which include transcriptional regulators such as the major flagella gene regulator, the 
AAA+ ATPase enhancer-binding protein FleQ in P. aeruginosa, and VpsT, a CsgD-family 
transcriptional factor of V. cholerae involved in regulating biofilm formation (27, 58, 69). In 
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mammals, STING (stimulator of interferon genes) is a direct innate immune sensor of c-di-
GMP (70).  
The first identified c-di-GMP protein receptor was the PilZ domain protein YcgR (71, 72). The 
PilZ domain is widespread in bacteria from different branches of the phylogenetic tree. The 
PilZ domain can be coupled to a variety of other domains and affect their catalytic or protein 
binding activity (73). The C terminus of the cellulose synthase BcsA of G. xylinus, the flagellar-
break YcgR from E. coli, the DgrA protein from C. crescentus, and the PlzC and PlzD from V. 
cholerae are identified PilZ domain c-di-GMP receptors (71, 74-76). Upon c-di-GMP binding 
the PilZ domain protein YcgR undergoes a profound conformational change to inhibit the 
flagella associated motility through protein-protein interactions. The conformational change 
upon c-di-GMP binding has been utilized to construct an in vivo c-di-GMP sensor based on the 
alteration in Förster transfer between the fluorophores (77). Equally binding of c-di-GMP to 
the PilZ domain protein BcsA activates cellulose biosynthesis (10, 23, 78). The conserved 
sequence motifs RxxxR and [D/N]xSxxG of PilZ domains, which are responsible for c-di-GMP 
binding, were disclosed by bioinformatics analyses and subsequently determination of crystal 
structures and biochemical experiments confirmed their role in c-di-GMP binding (61, 71). 
Cyclic di-GMP can also bind to the I-site of GGDEF domains, which allosterically inhibits c-
di-GMP synthesis by active DGCs. However, even degenerated GGDEF domains deficient in 
DGC activity can serve as c-di-GMP receptors. As such, PopA from C. crescentus contains a 
catalytically non-functional GGDEF domain, but serves still as a c-di-GMP receptor as it binds 
c-di-GMP through its functional I-site (79). In EAL domain proteins, such as SgmT from M. 
xanthus, PelD and FimX from P. aeruginosa, the substrate binding site of a defunct EAL 
domain functions as the c-di-GMP binding site (32, 80, 81).  
Another widespread type of receptor is the MshEN domain. In V. cholerae, two MshE domain 
ATPases involved in the bacterial type II secretion system (T2SS) and type IV pilus formation 
were found to specifically bind c-di-GMP (82-84). As one of the first receptors, the cAMP 
Receptor-Like Protein CLP was identified as a novel c-di-GMP receptor coordinating cell–cell 
signaling to virulence gene expression in Xanthomonas campestris (85). Moreover, in E. coli 
c-di-GMP also directly binds to polynucleotide phosphorylase (PNPase) which processes 
mRNA transcripts to regulate signal dependent RNA processing (86).  
Besides binding to protein receptors, c-di-GMP binds to riboswitches such as GEMM domain 
riboswitches to transcriptionally and post-transcriptionally regulate target gene expression and 
translation (87, 88). Riboswitches are sequences in the 5’ untranslated region of bacterial 
mRNAs that consist of an aptamer capable of binding small molecules whereby the structural 
change upon binding allows to regulate a downstream expression platform for gene 
transcription or protein translation (87, 89). So far, two main classes, the c-di-GMP I and II 
riboswitches, which can function as ‘on’ and ‘off’ riboswitches, with elevated c-di-GMP 
triggering and inhibition transcription or translation, respectively, have been identified. 
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1.2 CYCLIC DI-AMP 
The bacterial second messenger cyclic di-AMP (c-di-AMP) was originally discovered upon 
elucidation of the crystal structure of the sporulation checkpoint protein DisA from 
Thermotoga maritima by Hopfner and colleagues in 2008 (90-92). Subsequently, a consecutive 
physiological role for c-di-AMP signaling has emerged from the analyses of this signaling 
pathway in several Gram-positive bacteria and mycobacteria including S. aureus, M. 
tuberculosis, M. smegmatis, B. subtilis, B. thuringiensis, L. monocytogenes, S. pyogenes and S. 
pneumoniae and Lactococcus lactis, but also in some Gram-negative bacteria such as 
Chlamydia trachomatis and Borrelia burgdorferi, as well as in archaea (93-98). Concluded 
from these studies, c-di-AMP is considered as a broadly conserved second messenger with a 
delicate homeostasis required for optimal microbial growth and physiology, with effects on, 
for example, DNA integrity, cell-wall synthesis, osmoprotection, potassium homeostasis and 
virulence (1, 99) (Figure 4). In mammals, c-di-AMP binds the cytosolic DNA sensor STING 
and induces the production of type I interferons (IFNs) in response to pathogen infections (97). 
 
Figure 4 Overview of the c-di-AMP signaling network in bacteria. Cyclic di-AMP is produced 
by DAC domain diadenylate cyclases and degraded by PDEs with DHH-DHHA1 or HDc 
domains. Cyclic di-AMP is sensed by protein or RNA receptors, including RCK_C domains, 
USP domains, CBS pair domains, and riboswitches e.g. the YdaO riboswitch (100). The 
diagram shows the protein domains involved in c-di-AMP turnover and signaling.  
1.2.1 C-di-AMP metabolism 
As for each second messenger, the cellular concentration of c-di-AMP is tightly regulated and 
indeed, overexpression and depletion of c-di-AMP is deleterious (101). Cyclic di-AMP is 
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activity (91). Up to now, the DAC domain is the only domain that has been identified to 
perform c-di-AMP synthesis in vivo (102). The active pocket of DACs contains two metal ions 
which coordinate the phosphate group of the two ATP molecules. A condensation reaction of 
the two ATP molecules by active site residues produces c-di-AMP. The DAC domain is 
conserved among bacteria and archaea and is characterized by a catalytic site containing the 
conserved RHR and DGA motifs (90, 103, 104). DAC domain enzymes of different classes 
have been reported from multiple bacteria such as DisA, CdaA and CdaS from B. subtilis, 
CdaA from S. pyogenes, CdaA from S. pneumoniae, MtDisA from M. tuberculosis, CdaA from 
C. trachomatis, and CdaA from L. monocytogenes (90, 95-97, 105-107). Moreover, the DAC 
domain and c-di-AMP signaling seem to be as widespread as the GGDEF and EAL domains, 
however, usually only 1-3 DAC domain proteins are encoded per genome (91, 92). 
Cyclic di-AMP is subsequently degraded into linear pApA or AMP by PDEs (106, 108). Up to 
now, two major classes of PDEs have been identified to degrade c-di-AMP. The first is the 
DHH-DHHA1 family PDEs, such as GdpP from B. subtilis, which is characterized by the 
DHH-DHHA1 catalytic domain coupled to two transmembrane helical domains, a signal-
sensing PAS domain and a degenerate GGDEF domain (109). A related type of PDE contains 
the catalytic DHH-DHHA1 domain only, such as DhhP from B. burgdorferi, Pde1 and Pde2 
from S. pneumoniae, and CnpB from M. tuberculosis (106, 110-112). The second type of PDE, 
which belongs to the 7TMR-HD family, possesses a catalytic histidine-aspartate (HD) domain, 
such as PgpH from B. subtilis (113) and L. monocytogenes (114). 
1.2.2 C-di-AMP receptors 
The identified bacterial c-di-AMP receptors encompass RNA riboswitches (115), and domains 
associated with transcriptional regulators (116, 117) and ion uptake (92). The first identified c-
di-AMP receptor is DarR, a transcriptional regulator that belongs to the TetR family in M. 
smegmatis (117). Upon binding c-di-AMP, the DNA binding activity of DarR is enhanced and 
negatively regulates target gene expression and fatty acids synthesis (117). Another identified 
c-di-AMP receptor is KtrA, the potassium uptake transporter subunit which binds c-di-AMP 
within its RCK_C domain to contribute to S. aureus growth under low K+ conditions (118). 
Moreover, the RCK_C domain protein CpaA and the histidine kinase protein KdpD from S. 
aureus and CabP from S. pneumoniae have also been identified as c-di-AMP receptors to 
regulate K+ transport (118, 119). Other identified c-di-AMP receptors include DarA from B. 
subtilis and PstA from S. aureus (120, 121), both of which are PII-like signal transduction 
proteins, and LmPC from L. monocytogenes (116). Besides, c-di-AMP also binds to RNA 
riboswitches, e.g. the ydaO riboswitch, to regulate gene expression in response to intracellular 
ATP (115, 122). 
1.3 CYCLIC GAMP AS A SECOND MESSENGER 
In 2012, a hybrid cyclic GMP-AMP (3’3’-cGAMP) molecule was identified as a new type of 
bacterial cDNs in V. cholerae O1 biovar El Tor 7th pandemic strains by John J. Mekalanos and 
colleagues (4). Whereas the specific enzyme classes that produce, degrade, and respond to both 
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c-di-GMP and c-di-AMP second messenger signaling have been well described, all consecutive 
components of the 3’3’-cGAMP signaling pathway, synthase, phosphodiesterase, receptor and 
target output, have only been uncovered in V. cholerae (Figure 5).  
1.3.1 3’3’-cGAMP synthesis 
The novel bacterial second messenger 3’3’-cGAMP is synthesized by a novel class of 
dinucleotide cyclases termed DncV, which are sequentially and structurally distinct from 
classical c-di-GMP as well as c-di-AMP cyclases. In V. cholerae El Tor, DncV is required for 
efficient intestinal colonization and chemotaxis, a phenotype previously associated with hyper-
infectivity (4). The presence of DncV homologs has been predicted for other bacterial species, 
suggesting a more global signaling role for 3’3’-cGAMP signaling (123-125). Genome 
analyses showed a homolog of DncV to be present, for example, in the E. coli commensal strain 
ECOR31 (ATCC 35350) from the E. coli reference (ECOR) collection (126-128). ECOR31 
contains a high-pathogenicity island (HPI) encoding the siderophore yersiniabactin (Ybt), 
which was first identified in Y. pestis as a widely distributed virulence determinant among E. 
coli and other Enterobacteriaceae species that cause extra-intestinal infections (126, 129). 
ECOR31 HPI comprises an additional 35 kb fragment at the right border (RB) compared to the 
HPI of E. coli CFT073 and Yersinia species; the homolog of dncV is located on this fragment 
flanked up- and downstream by V. cholerae 7th pandemic island-1 (VSP-1) homologs of capV, 
vc0180, and vc0181 (126, 130). Studies from our laboratory demonstrated DncV to synthesize 
3’3’-cGAMP and to regulate biofilm formation and motility in ECOR31 (130). Others have 
shown that dncV and adjacent proteins are involved in the resistance against phage infections 
in E. coli (124). DncV homologs have also been detected in clinically relevant species such as 
Enterobacter and hypervirulent Klebsiella pneumoniae (130). In V. cholerae, CapV was 
identified as a cGAMP-activated phospholipase that leads to growth retardation upon 
overexpression (131). Moreover, based on structural and in vitro evidence, the catalytic activity 
of V. cholerae DncV is inhibited by folates (132).  
Besides the di-nucleotide cyclase DncV, a sub-class of GGDEF domains, the hybrid 
promiscuous (Hypr) GGDEF enzymes, which are homologs to and structurally highly related 
to the GGDEF family of diguanylate cyclases (DGCs) associated with the c-di-GMP signaling 
pathway, were also identified to produce 3’3’-cGAMP. Those enzymes are, for example, 
involved in regulation of genes associated with extracellular electron uptake in the Gram-
negative bacterium Geobacter sulfurreducens (133-135). The Hypr GGDEF homologs are also 
found in divers other bacterial species, including the predatory species Bdellovibrio 
bacteriovorus (now within the class Oligoflexia) and social myxobacterial species such as 
Myxococcus xanthus (133). 
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Figure 5 Overview of the 3’3’-cGAMP signaling network. 3’3’-cGAMP is produced by the 
GAC DncV and proteins with Hypr GGDEF domain and degraded by PDEs with HD-GYP 
domains. 3’3’-cGAMP is sensed by protein or RNA receptors, including CapV from V. 
cholerae (131), RECON (136) and STING (137) in mammals, and riboswitches e.g. GEMM-
1b riboswitch (138). The diagram shows the protein domains involved in 3’3’-cGAMP 
metabolism and signaling as identified in V. cholerae and Geobacter spp. 
Biochemical studies showed that the bacterial cGAMP contains two 3’-OH-5’-phosphate 
phosphodiester bonds (cyclic G(3’,5’)pA(3’,5’)p; 3’3’-cGAMP) characteristic for bacterial 
cyclic di-nucleotide signaling molecules (139). Besides producing 3’3’-cGAMP, two GTP or 
ATP molecules can also fit into the catalytic pocket of DncV, which generates the 
corresponding cyclic dimeric GMP (c-di-GMP) and c-di-AMP molecules in vitro, suggesting 
that one enzyme might also synthesize multiple cDNs in bacterial cells (4, 138). However, the 
predominant product of DncV is 3’3’-cGAMP with GTP and ATP predominantly used as 
substrates both in vitro and in vivo (4, 139, 140). These studies suggest DncV to preferably 
recognize ATP and GTP as acceptor and donor nucleotides. Structural studies determined that 
DncV comprises an elongated pocket for binding the nucleotide substrates in the middle of the 
enzyme, which is flanked by two distinct domains. The catalytic residues, Asp131, Asp133, 
and Asp193, characteristic for nucleotidyl transferases, are located on a β sheet at the bottom 
of the pocket, with two Mg2+ ions and two nucleotides bound to the active site (132, 141) 
(Figure 6). Despite the low sequence identity (<10%), the structure of bacterial DncV is highly 
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Figure 6 Crystal structure of DncV from V. cholerae containing a bound linear dinucleotide 
intermediate pp(c)pA[3’-5’]pG shown as a ribbon representation (PDB 4TY0) (144). The 
bound Mg2+ ions and nucleotides are shown as green spheres and as ball-and-stick model, 
respectively.  
In eukaryotes, the cGAS produced cGAMP subsequently stimulates the adaptor protein STING 
and thereby promotes a type I interferon innate immune response in mammalian cells. 
Biochemical studies have demonstrated that the mammalian cGAMP comprises a canonical 
3’5’ phosphodiester bond and a non-canonical 2’5’ phosphodiester bond (cyclic 
G(2’,5’)pA(3’,5’)p; 2’3’ cGAMP) (4, 139, 140). Subsequently structural studies revealed that 
cGAS sequentially catalyzes the reactions in one active site within the nucleotide acceptor and 
donor pockets (145, 146). The first reaction starts with the formation of the 2’5’ phosphodiester 
linkage between GTP and ATP bound to the acceptor and donor pockets, respectively, to 
produce a linear pppG(2’,5’)pA intermediate molecule which subsequently rebinds to the 
catalytic pocket in the reverse direction. Secondly, the 3’5’ phosphodiester linkage within the 
linear pppG(2’,5’)pA intermediate is formed leading to the production of 2’3’-cGAMP (Figure 
7) (141, 144).  
Distinct from eukaryotic cGAS, which produces 2’3’-cGAMP only upon binding of DNA, 
DncV is constitutively active to produce 3’3’-cGAMP in vitro (4, 139, 140, 143). However, 
the catalytic activity of DncV is inhibited by folic acid and its derivatives such as 5-
methyltetrahydrofolate diglutamate, which was found to bind to a pocket opposite to the 
catalytic side upon determination of the crystal structure (132). DncV functions as a monomer 
and does not undergo major conformational changes upon substrate binding. Furthermore, 
DncV lacks regulatory dimerization contacts as observed in eukaryotic cGAS and conventional 
bacterial cyclic dinucleotide cyclases (90, 141, 144, 147-149). Similar to eukaryotic cGAS, 
DncV also produces cGAMP through sequential reactions in one active site. Crystallization of 
DncV with the linear dinucleotide intermediate pp(c)pA[3’-5’]pG indicated that the first step 
in DncV nucleotide cyclization occurs through the attack of the 3’ hydroxyl of the ribose of 
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and GTP as the electrophile acceptor; while in the second step, the 3’ hydroxyl of the ribose of 
guanosine attacks the α-phosphate group of the adenosine, to eventually form 3’3’-cGAMP 
(A[3’-5’]pG[3’-5’]p) (144) (Figure 7).  
 
 
Figure 7 Schematic model of the two-step process of cGAS- (above) and DncV-catalyzed 
(below) cyclic dinucleotide product synthesis. 
In contrast to cGAS and DncV, both of which produce 2’3’- and 3’3’-cGAMP, respectively,via 
a linear dinucleotide intermediate at one active site, the Hpyr GGDEF enzyme, e.g. GacA, a 
homodimeric enzyme from G. sulfurreducens, uses either of the nucleotides as a substrate in 
the first bond-forming step, which generates both types of linear intermediates (pp(c)pA[3’-
5’]pG and pppG(2’,5’)pA), to produce 3’3’-cGAMP (135). Besides bacterial DncV and Hypr 
GGDEF domain proteins as 3’3’-cGAMP cyclases, 3’3’-cGAMP has been observed to be 
produced by the cGAMP synthase in the anemone Nematostella vectensis (150). 
1.3.2 3’3’-cGAMP hydrolysis 
Using an eukaryotic screening system, the first cGAMP-specific PDEs were identified as HD-
GYP domain proteins, named V-cGAP1/2/3 in V. cholerae (151). All three PDEs were able to 
degrade 3’3’-cGAMP, but not other cGAMP analogues such as 2’3’, 2’2’, 3’2’-cGAMP. 3’3’-
cGAMP is first hydrolyzed to linear 5’-pApG by all three V-cGAPs, which is subsequently 
further cleaved into 5’-ApG in a second step by V-cGAP1 via its 5’-nucleotidase activity (151). 
Structural studies showed that compared to other characterized HD-GYP domain protein 
structures which contain only one HD-GYP domain (53, 152, 153), V-cGAP3 contains a novel 
tandem HD-GYP domain within its N- and C-terminal domain, the structures of which are 
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Supplementary Figure 9 | Enzymatic assays reveal the endogenous cGAS product to be 
(>Gp(2’-5’)Ap(3’-5’)>). (a) Chromatograms and schematic view of the reaction products from (a) RNase T2, 
(b) S1 Nuclease, (c) RNase T1 and (d) SVPDE digestion of synthetic cGAMP(3’-5’) (dark blue) and in cellulo 
synthesized cGAS product (light blue). Representative data out of two independent experiments are shown. 
Peaks marked with #, §, ** and *** represent phenol contamination, not assignable peaks (no ESI-MS signal), 
chemical synthesis by-products and isomerization products, respectively.
A[3’-5’]pG[3’-5’]p
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cGAP3 is catalytically nonfunctional, but can enhance the catalytic activity of functional C-
terminal domain. Upon binding with 3’3’-cGAMP, the C-terminal domain of V-cGAP3 
undergoes a conformational change to form a bi-nuclear metal center for 3’3’-cGAMP and two 
Mg2+ (154).  
The discovery of the V. cholerae V-cGAPs on 3’3’-cGAMP indicates the existence of specific 
PDEs of cGAMP in other bacteria, including the mammalian 2’3’-cGAMP. Recently, 
ectonucleotide pyrophosphatase/phosphodiesterase (ENPP1) was identified as the dominant 
2’3’-cGAMP PDE using biochemical studies (155). In contrast to V-cGAPs that only degrades 
3’3’-cGAMP, ENPP1 can hydrolyze not only 3’2’-cGAMP, but also 3’3’-cGAMP in vitro, but 
preferentially hydrolizes 2’3’-cGAMP (155, 156). Structural studies showed that 2’3’-cGAMP, 
but not 3’3’-cGAMP, binds to the active site of ENPP1 in a conformation suitable for the in-
line attack by the catalytic residue Thr238, resulting in the specific hydrolysis of 2’3’-cGAMP 
by ENPP1 (157). 
Besides V-cGAPs, the HD-GYP domain protein PmxA was recently identified as a 3’3’-
cGAMP specific PDE that promotes resistance to osmotic stress in M. xanthus (158). In 
contrast to V-cGAPs, which can actually hydrolyze any guanine nucleobase containing 
molecules (151),  PmxA, which contains a Qxx(K/R) motif instead of the canonical Rxx(K/R) 
motif in the HD-GYP domain, preferentially degrades 3’3’-cGAMP over c-di-GMP (158), 
suggesting the glutamine of the Qxx(K/R) motif may serve as a signature residue for the 
substrate specificity of HD-GYP domain PDEs.  
1.3.3 3’3’-cGAMP receptors 
The first protein receptor identified for 3’3’-cGAMP has been CapV from V. cholerae El Tor 
(131). Genomic analysis shows that capV is located immediately upstream of dncV, the gene 
which encodes the novel bacterial second messenger 3’3’-cGAMP, on the VSP-1 island of V. 
cholerae El Tor (4). CapV contains a canonical patatin-like phospholipase A (PNPLA) domain 
which belongs to the phospholipase A2 (PLA2) superfamily (159). PLA2 and PLA1 are two 
major subclasses of the PLA superfamily. PLA2 catalytically cleaves the sn-2 position of acyl 
chain of phospholipids, while PLA1 cleaves the sn-1 position, both release free fatty acid and 
lysophospholipid (160, 161). Patatin-like phospholipases (PLPs) have been originally reported 
in plants and are, for example, potato tuber storage proteins (162, 163), are a subfamily of PLA2 
enzymes. PNPLA domain PLPs are distributed both in plants and mammals. In plants, PLPs 
do not only act as enzymes to cleave fatty acids from membrane lipids, but also contribute to 
the defense against plant pathogens, while in mammals, PLPs are mostly involved in lipid 
metabolism and turnover (164). Besides plants and mammals, PLPs are also widespread in 
bacteria, particularly Gram-negative species. For example, ExoU, one well characterized PLP 
in P. aeruginosa, is activated by host ubiquitin and targets host cell membranes as a cytotoxic 
effector through the type III secretion system (T3SS) (165-168). But the ubiquitin is not the 
only activator for PLPs enzymatic activity. In V. cholerae El Tor, the phospholipase activity of 
CapV was activated upon binding to the novel bacterial second messenger 3’3’-cGAMP, 
leading to the degradation of specific bacterial cell membrane phospholipids including 
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phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) and the release of free fatty 
acids (FFAs) and lysophospholipids to eventually cause cell death (131).  
The first 3’3’-cGAMP riboswitch was developed based on the c-di-GMP class I riboswitches 
(169, 170). Recent studies showed that similar to c-di-GMP, 3’3’-cGAMP in the Gram-
negative environmental bacterium G. sulfurreducens utilizes a subclass of GEMM-I (GEMM-
I b, Genes for the Environment, Membranes, and Motility) class riboswitch as specific receptor 
to regulate genes involved in exoelectrogenesis (134, 138). In addition, 3’3’-cGAMP signaling 
was found to be activated by the second messenger cyclic AMP (cAMP), but inhibited by c-
di-GMP (158), suggesting a cross regulation of these nucleotide-based second messenger 
signaling pathways. However, no other receptors, effectors and activators of bacterial 3’3’-
cGAMP signaling have been identified. 
1.4 ADDITIONAL CYCLIC NUCLEOTIDE SECOND MESSENGERS 
Furthermore, in recent years, there had been an explosion in the discovery of various bacterial 
cyclic di- and multiple nucleotide second messengers. CdnE, which is located on the horizonal 
transferred RB-HPI of E. coli ECOR31, uses both purine and pyrimidine nucleotides to 
synthesize cyclic UMP-AMP. Other homologs synthesize a diverse range of cDNs, including 
the cyclic trinucleotide AMP-AMP-GMP (125). Bioinformatic and biochemical analyses 
suggest CdnE to be a member of the cGAS/DncV-like nucleotidyltransferases (CD-NTases) 
family with homologs present in nearly every bacterial phylum. Similar to c-di-AMP and 3’3’-
cGAMP, cyclic UMP-AMP and cyclic AMP-AMP-GMP can also bind to the RECON receptor 
in mammalian cells, but block its activity rather than stimulate it (125). The biological role of 
these molecules in bacteria, though, is still unknown.  Besides cyclic di- and tri-nucleotides, 
cyclic oligonucleotides have recently been identified in bacteria embedded in CRISPR/Cas 
(clustered regularly interspaced short palindromic repeats and CRISPR-associated genes) 
antiviral defense systems (171, 172).  For example, in Streptococcus thermophilus, Csm, an 
effector complex that is involved in bacterial type III CRISPR-Cas systems, synthesizes cyclic 
oligoadenylates (cAn; n = 2 to 6) via a GGDEF domain homolog, and then binds Csm6 
ribonuclease to activate its nonspecific RNA degradation to prevent phage infection and 
propagation (171, 172). 
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2 AIMS OF THE THESIS  
1. Providing the molecular basis to assess the regulatory mechanisms of semiconstitutive rdar 
biofilm formation by sequencing the genomes of eight semiconstitutive rdar biofilm 
forming commensal and uropathogenic E. coli strains by Illumina Miseq or PacBio 
sequencing (Paper I). 
2. Definition of the cGAMP signaling network and investigation of its physiological impact 
and molecular mechanisms to regulate of rdar biofilm formation and motility in the animal 
commensal strain E. coli ECOR31 (Paper II). 
3. Characterization of the role of CapV and CapVQ329R in the regulation of  E. coli 
phenotypes such as cell morphology, flagella biosynthesis and activity and csgD dependent 
rdar biofilm formation (Paper III). 
4. Analysis of the molecular basis of temperature-independent expression of the csgD 
dependent rdar morphotype by c-di-GMP turnover proteins in seven semiconstitutive rdar 
biofilm forming E. coli strains. In particular, to investigate the role of the c-di-GMP 
phosphodiesterase/diguanylate cyclase/trigger enzyme YciR to regulate rdar biofilm 
formation and csgD expression (Paper IV). 
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3 MATERIALS AND METHODS 
Experimental methods frequently and uniquely used in this thesis are described below. A 
detailed description of experimental methods can be found in the Materials and Methods 
section of each paper. 
3.1 DNA MANIPULATION OF E. COLI 
Construction of gene deletions was performed by using the recombineering vector pSIM7, 
according to a protocol published previously with slight modifications (173). This plasmid is 
composed of an origin of replication and a segment of the bacteriophage λ genome comprising 
the Red recombinase genes (exo, bet and gam) under their native transcriptional control from 
the pL promoter and the temperature-sensitive repressor CI857, a variant of native CI repressor. 
At low temperature (30 - 34°C), the repressor is active and blocks the pL promoter, shutting 
off transcription of the Red genes. Following a brief temperature shift to 42°C results in a 
transient denaturation of the repressor, allowing the expression of gam, bet and exo. Upon 
transformation of PCR created dsDNA composed of an antibiotic marker flanked by FRT 
(Flippase recognition target) sites and nucleotide sequences homologous to the start and stop 
region of the target gene as short as 30 nucleotides, a gene can be replaced by the antibiotic 
resistance cassette. Upon shifting back to low temperature (30 - 34°C), the repressor again 
renatures and binds to pL, to turns off the Red system. The recombinant colonies can be selected 
on agar plates containing the respective antibiotic. The antibiotic marker can be excised using 
another temperature-sensitive helper plasmid, e.g. pCP20, which encodes the FLP recombinase 
that acts directly on the flanking FRT sites to excise the antibiotic gene marker. 
3.2 PHENOTYPIC ANALYSES 
3.2.1 Rdar morphotype 
Predominantly sessile multicellular behavior, also known as biofilm formation, is a universal 
character of bacteria important for transmission, colonization and persistent infections. The 
rdar (red, dry and rough) morphotype commonly expressed by S. typhimurium and E. coli is a 
well-established biofilm model visualized by growth of bacteria on LB without salt agar plates 
as a distinct colony morphology. It is characterized by the expression of the adhesive biofilm 
extracellular matrix components cellulose and curli fimbriae, both of which can selectively 
bind to the dye Congo Red. Colonies were photographed at different time points to analyze the 
development of the morphology of the macrocolony and dye binding capacity indicative for 
differential expression of extracellular matrix components. 
3.2.2 Motility assay 
Apparent flagella-mediated swimming motility has been analyzed by measuring the swimming 
diameter in tryptone broth containing 0.25% agar, 0.5% NaCl, and 1% tryptone (23). 
Inoculation of bacteria into the agar of such a plate promotes movement of bacteria through the 
agar that can be detected as a ring or halo that enlarges over time depending on the ability of 
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the bacteria to swim and to conduct chemotaxis. Upon lack of apparent swimming motility, 
isolation of bacterial cell-associated flagellin can be a first step to extend and complement the 
flagella-mediated swimming motility assay in order to assess the molecular mechanisms of 
apparent swimming deficiency e.g. upon deletion of a gene or overexpression of a gene product. 
3.2.3 Aggregation assay 
Many bacterial cells including E. coli cells can bind to each other which is termed 
autoaggregation (174). Autoaggregation can be observed combining microscopic and 
macroscopic observation of the formation of bacterial multicellular aggregates that settle to the 
bottom of the culture medium when reaching a certain size. Bacterial aggregation was visually 
observed throughout the growth phase for up to 24 h in conjunction with detection of 
expression of the major biofilm regulator CsgD by Western blot analysis. 
3.2.4  Biofilm formation on abiotic surfaces 
Bacterial adhesion to abiotic surfaces under suitable growth conditions is an often used biofilm 
model (12, 175). Crystal violet staining of adherent cells and subsequent OD measurement of 
the amount of the bound dye after dissolution is a commonly used method to initially assess 
biofilm formation, for example, in a 96 well microtiter plate format. Crystal violet is a dye that 
interacts with negatively charged molecules (i.e., peptidoglycan) and the extracellular 
polysaccharide matrix (176), which makes it not only suitable for measuring the amount of 
biofilm, but also for the visualization of the pattern of biofilm distribution in the well.  
3.3 ELECTRON MICROSCOPY 
Electron microscopy (EM) uses the diffraction of electron to create an image of biological 
samples with high resolution. It is a commonly used technique for investigating the detailed 
structures of various biological samples (177). Transmission EM (TEM) and the scanning EM 
(SEM) are two major types of electron microscopy. In microbiology, TEM can be used, for 
example, to image the bacterial cell and the organization of bacterial filaments, e.g. the 
flagellum, in conjunction with the negative staining technique. SEM can be used to assess the 
details of bacterial cell morphology and atomic compositions in conjunction with secondary 
detectors. 
3.4 REAL-TIME QUANTITATIVE REVERSE TRANSCRIPTION PCR 
Real-Time Quantitative Reverse Transcription PCR (qRT-PCR) is a nucleotide amplification-
based method to detect and measure the mRNA levels for a target gene (178). To allow 
assessment of expression of the initial transcript, the mRNA is first transcribed into DNA by 
template-dependent reverse transcriptase. The double stranded DNA template is then 
exponentially amplified which allows relative quantification of the initial concentration 
according to the number of cycles required before a certain threshold concentration of the 
amplified DNA is reached. Two common methods have been applied for monitoring the 
amount of the PCR products generated by qRT-PCR: non-specific fluorescent dyes and 
sequence-specific DNA probes. The first approach uses a fluorescent dye, such as SYBR Green, 
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that intercalates non-specifically with any double-stranded DNA product, including PCR 
products; while the other approach consists of fluorescent reporter labelled oligonucleotides 
probe, which only detects DNA containing its complementary sequence. The two approaches 
require housekeeping gene(s) as internal standard for normalization, which are selected based 
on their almost constant level of expression. In this thesis, qRT-PCR was run with monitoring 
by SYBR green and the data were analyzed by the 2-ΔΔCT method (179). The rpsV gene was 
used as an endogenous control for internal normalization. 
3.5 PROTEIN BIOCHEMICAL ASSAYS 
3.5.1 Western blot analysis 
Western blot is a widely applied technique used in cell and molecular biology to estimate the 
relative or absolute amount of expression of specific proteins within a cell extract after 
separation by protein gels (180). Proteins in a cell extract are separated by SDS-PAGE gel 
electrophoresis based on their negative charge upon binding of the sodium dodecyl sulfate 
detergent molecules which is correlated with the molecular weight, followed by an 
electrophoretic transfer onto a nitrocellulose or PVDF membrane. The membrane is then 
incubated with an antibody that recognizes specific epitope(s) of the protein of interest. The 
constant part of the first antibody is subsequently recognized by a secondary antibody to which 
e.g. a dye or an enzyme (frequently horseradish peroxidase) is covalently coupled. Oxidation 
of the substrate luminol by hydrogen peroxide results in the production of a chemo fluorescence 
signal which can be monitored. 
3.5.2 Protein purification by affinity tag 
Protein purification is a basic experimental approach that will subsequently allow 
characterization of functionality, structure and interactions of the protein of interest (181). 
Adding specific affinity tags, e.g. a 6*His-tag, to the protein of interest simplifies the 
purification of a recombinant fusion protein by employing affinity column chromatography for 
purification. During purification, the 6*His-tag of the protein of interest selectively binds 
divalent metal ions such as nickel and cobalt on affinized resin, while all untagged proteins 
pass through the column. The 6*His-tagged protein can be eluted with imidazole, which 
competes with the 6*His tag for binding to the column, or by a reduced pH (typically to 4.5 - 
5.3), which decreases the affinity of the tag for the resin. The enzymatic activity of the purified 
protein can be subsequently assessed by the respective enzymatic assay. 
3.5.3 Thin layer chromatography 
Thin layer chromatography (TLC) is a straightforward method to analyze mixtures of small 
molecules by separating the compounds in the mixture by liquid/solid phase separation using 
e.g. an immobilized silica matrix coated on a support plate as the solid phase (182). TLC can 
be used to aid the determination of the complexity in a mixture, unravel the identity of a 
compound and assess the purity of a compound. As the solvent front subsequently moves along 
the stationary phase of the plate by capillary forces, for each molecule, an equilibrium is 
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established between adsorption onto the solid phase and dissolution in the solution. Due to their 
chemical structure and charge as well as the nature of the solid phase, the components differ in 
solubility and in the strength of their absorption to the absorbent, this equilibrium results in 
some components to be carried further up the plate than others. This distinct running behavior 
is quite reproducible for a given system and characterized by the Rf value. Thus, TLC was used 
to primarily analyze the enzymatic products of the respective proteins. Using a silica solid 
phase that contains a fluorescence indicator can detect molecules such as nucleotides that 
absorb light of the same wave length. 
3.5.4 Tandem mass spectrometry 
Tandem mass spectrometry (MS/MS) is a technique where two or more mass spectrometers 
are consecutively coupled to increase their resolution to analyze protein or peptides samples 
(183).  The compounds are ionized and separated according to their mass-to-charge ratio (m/z) 
by one mass spectrometer and fragmented by a second mass spectrometer by their m/z ratio for 
identification. The enzymatic products of DncV were scraped out from the TLC plate to be 
identified by MS/MS using standard compounds.  
3.6 BIOINFORMATIC ANALYSIS 
3.6.1 Assembly and annotation of genomic DNA sequences 
The genomic DNA from E. coli strains Tob1 and ECOR31 was sequenced with the PacBio RS 
II system (Pacific Biosciences; NGI Uppsala, Science For Life Laboratory [SciLifeLab], 
Uppsala, Sweden). The assembly was done on SMRT portal version 2.3, using HGAP3 with 
default settings. The genomic DNA from E. coli strains Fec67, Fec101, No.12, and B-11870 
was sequenced using an Illumina MiSeq version 3 platform with read length up to 2 * 300 bp 
(NGI Stockholm, SciLifeLab, Solna, Sweden). De novo assembly was performed using 
SPAdes (http://bioinf.spbau.ru/spades), with contigs smaller than 500 bp omitted (184). The 
coverage was calculated according to Lander and Waterman (185). Initial analysis was 
performed by the Rapid Annotations using Subsystems Technology (RAST; version 2.0) server 
(http:// rast.nmpdr.org/rast.cgi) (186, 187). Genome sequences were submitted to 
DDBJ/ENA/GenBank and annotated with the NCBI Prokaryotic Genome Annotation Pipeline. 
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4 RESULTS AND DISCUSSION 
4.1 PAPER I: DRAFT GENOME SEQUENCES OF SEMICONSTITUTIVE RED, 
DRY, AND ROUGH BIOFILM-FORMING COMMENSAL AND 
UROPATHOGENIC ESCHERICHIA COLI ISOLATES 
E. coli is a well-studied model organism for various aspects of bacterial physiology and 
behavior. Biofilm formation is defined as multicellular microbial communities surrounded by 
a self-produced matrix of extracellular polymeric and non-polymeric substances adherent to 
each other, to interfaces and/or to biotic or abiotic surfaces (188). Strains of E. coli were proven 
to exhibit diverse biofilm phenotypes. A well-studied biofilm type characterized by the 
formation of an extracellular matrix consisting mainly of amyloid curli fimbriae and the 
exopolysaccharide cellulose is the red, dry, and rough (rdar) morphotype. Whereas E. coli K-
12 model strains express at most a rudimentary rdar morphotype without production of 
cellulose exclusively at temperature below 30°C (18, 189), clinical isolates have been shown 
to frequently form the rdar morphotype semi-constitutively at 30°C and body temperature (190-
192). 
In this study, the genomes of eight semi-constitutive rdar biofilm forming E. coli strains 
including E. coli commensal strains Tob1, Fec67, Fec101, and ECOR31, E. coli UPEC strains 
No.12, B-11870, 80//6 and B8638 were sequenced by Illumina Miseq or PacBio sequencing. 
PacBio sequencing gave rise to 4 contigs for the human commensal strain E. coli Tob1(one 
plasmid) and 6 contigs for E. coli ECOR31 (three plasmids). The Illumina sequencing followed 
by SPAdes assembly resulted in assembly of the respective genomes into 90-140 scaffolds. In 
depth homology search by Blast (193) of characterized c-di-GMP turnover proteins showed 
that the ECOR31 genome comprises twelve proteins with a GGDEF domain, ten with an EAL 
domain and six with a GGDEF-EAL tandem. Besides, a putative 3’3’-cGAMP synthetase and 
putative c-di-AMP synthetase (DAC domain; data not shown) homolog have also been found 
encoded on the ECOR31 genome. All sequences have been submitted to the NCBI WGS 
database. In depth analysis of the sequenced genomes of semi-constitutive rdar morphotype 
expressing E. coli will shed light on the variability of the E. coli genomes, in particular, in this 
case, on the regulatory mechanisms of semi-constitutive versus temperature regulated rdar 
biofilm formation.
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4.2 PAPER II: DNCV SYNTHESIZES CYCLIC GMP-AMP AND REGULATES 
BIOFILM FORMATION AND MOTILITY IN ESCHERICHIA COLI ECOR31 
E. coli ECOR31 is an animal commensal strain isolated from leopard feces, which belongs to 
the E. coli reference strain collection (128). Similar to E. coli clinical isolates that usually shows 
semi-constitutive rdar morphotype expression, ECOR31 also displayed a semi-constitutive rdar 
morphotype on LB agar plates containing Congo Red at both 28°C and 37°C. Moreover, 
deletion of the csgBA genes encoding the major and minor subunits CsgA and CsgB of amyloid 
curli fimbriae, respectively, and bcsA encoding the cellulose synthase resulted in a pdar and 
bdar colony morphotype, respectively. The regulation of the rdar phenotype is controlled by 
the expression of the orphan response regulator CsgD protein, a transcriptional regulator. CsgD 
expression is regulated by a multitude of global regulatory pathways including the c-di-GMP 
signaling pathway in E. coli (18, 189). Cyclic di-GMP not only regulates the expression of 
cellulose and curli fimbriae, but also represses various modes of motility, such as flagellar-
mediated swimming and swarming motility. Consistently, a csgD deletion mutant resulted in a 
saw colony morphotype, while swimming motility was not affected. Overexpression of c-d-
GMP producing DGCs AdrA (7) and YdeH (7), upregulated the rdar morphotype and CsgD 
expression and downregulated swimming motility, while overexpression of c-d-GMP PDEs 
YhjH and YE2225 (194) downregulated the rdar morphotype and CsgD expression. 
Coexpression of AdrA or YdeH with increasing amounts of the PDE YhjH or YE2225 
gradually relieved the inhibitory effect of the DGCs on swimming motility of ECOR31. Taken 
together, these results indicate that the rdar morphotype is dependent on the transcriptional 
activator CsgD and c-di-GMP signals in ECOR31 as it has been observed in other E. coli strains 
and other bacterial species (18, 62, 191, 195). 
Bioinformatic analyses of the E. coli ECOR31 genome showed that it contains a DncV 
homolog (paper I), which has been demonstrated to synthesize 3’3’-cGAMP in V. cholerae 
biovar El Tor (4). ECOR31 contains a horizontally transferred high-pathogenicity island (HPI) 
encoding the siderophore yersiniabactin on the chromosome, which is a widely distributed 
virulence factor among E. coli, Yersinia spp. and other Enterobacteria that cause extra-
intestinal infections (126, 129). The dncV locus is located on the 34.5 kbp ECOR31 right border 
HPI (RB-HPI) (Figure 6). Compared with DncV of V. cholerae, DncV of ECOR31 shows 61% 
identity and 74% in similarity. Blast search for DncV homologues with >40% identity indicates 
that DncV is widely distributed in various bacterial species and with DncV homologs to be 
classified into at least three subgroups based on their phylogenetic relationship.  
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Figure 8 E. coli ECOR31 contains a horizonal transferred composite HPI homologs to the 
Yersiniabactin encoding HPI of Yersinia, E. coli and Klebsiella spp. and a RB-HPI, which 
contains part of the Vibrio 7th pandemic island-I (VSP-I) that encodes a 3’3’-cGAMP synthase 
dncV and its putative phospholipase receptor capV on a four gene operon. Grey arrow, HPI 
integration site. Blue boxes, direct repeat (DR) flanking the E. coli ECOR31 HPI. 
In V. cholerae, DncV was found to regulate virulence and chemotaxis (4). Structural studies of 
DncV of V. cholerae demonstrated that amino acid Q110 is required for GTP binding, while 
amino acids D131 and D133 are critical catalytic residues that bind Mg2+ (132, 141, 144). 
Interestingly, though deletion of dncV showed no obvious effect on rdar biofilm formation, 
dncV overexpression downregulated the rdar biofilm morphotype and CsgD expression, as well 
as cellulose and curli fimbriae expressions in E. coli ECOR31. In contrast, the catalytic mutants 
of DncV, DncVQ110A and DncVD129A/D131A, had no effect. Consistent with its effect on rdar 
morphotype expression, overexpression of dncV inhibited CsgD production leading to 
resolution of aggregate formation, while the two protein mutants had no effect compared to the 
ECOR31 vector control. qRT-PCR analysis showed that the mRNA levels of csgD were 
dramatically reduced upon dncV overexpression, but not upon overexpression of the mutant 
protein. On the other hand, overexpression of dncV enhanced biofilm formation on the abiotic 
surface after 24 h of growth in liquid culture, while it downregulated adherence after 48 h. 
Consistent with this finding, biofilm formation was down- and up-regulated, respectively, in 
the dncV deletion mutant. In conclusion, these data suggest the catalytic activity of dncV is 
required to negatively regulate the rdar morphotype and csgD mRNA steady state levels. The 
complex effect of dncV on biofilm formation indicated that dncV and/or 3’3’-cGAMP affects 
biofilm formation in multiple ways. 
Besides rdar biofilm formation, DncV also inhibited swimming and swarming motility of E. 
coli ECOR31, while the DncV catalytic mutants had no effect. Consistently, a dncV 
chromosomal deletion mutant enhanced swimming and swarming motility compared to the 
ECOR31 wild type. Interestingly, in V. cholerae, expression of dncV affected chemotaxis, but 
had no effect on motility and biofilm formation (4). Moreover, coexpression of the motility-
specific c-di-GMP PDE YhjH with DncV did not be relieved the swimming inhibition by DncV 
expression, indicating cGAMP may be responsible for the observed phenotype repression. 
Indeed, both the production of cell associated extracellular flagellin and the number of flagella 
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biosynthesis is a complex process that involves flagellar regulon genes divided into three 
classes (196). qRT-PCR analysis showed that the level of mRNA for flhD encoding class 1 
flagella regulator FlhD4C2 was not altered upon overexpression of dncV, while class 2 and class 
3 gene expression as estimated by expression of the gene fliA encoding the flagella specific 
sigma factor and fliC encoding the flagellar subunit protein FliC, respectively, was diminished 
upon dncV overexpression. These findings indicate that in ECOR31, dncV inhibits motility by 
interacting with class 1 flhDC genes at the post-transcriptional level. 
Results from the in vitro DncV enzymatic assay using purified DncV protein suggests that 
DncV can synthesize a major product which is different from c-di-AMP and c-di-GMP 
standards when incubated with its substrates ATP and GTP. Further analysis by MS/MS 
confirmed the product to be 3’3’-cyclic GAMP. Interestingly, using GTP and ATP as substrates, 
DncV can also synthesize c-di-GMP and c-di-AMP, respectively. In the presence of all four 
nucleotides, DncV only uses ATP or GTP, but not CTP or UTP as substrates, which indicates 
DncV to preferentially use purine nucleotide triphosphates as substrates. Interestingly, when 
incubated with CTP alone or GTP plus CTP, an unknown product was produced by DncV, 
suggesting that DncV can also use CTP as a substrate to some extent. This finding extends the 
substrate and possibly product spectrum of DncV homologs as a previous report documented 
that DncV from V. cholerae only uses ATP and/or GTP as a substrate(s) (4). By digestion with 
enzymes RNase T1, S1 nuclease, and RNase T2, the in vitro DncV synthesized products were 
confirmed to be 3’3’-cGAMP, 3’3’ c-di-GMP, and 3’3’ c-di-AMP, respectively. We also 
detected 3’3’-cGAMP upon overexpression of DncV in cell extracts, while in the vector control, 
upon overexpression of the catalytic mutant, no signal was detected. Moreover, the levels of in 
vitro bi-products c-di-GMP and c-di-AMP were under the detection limit in all assays.  
We also found that, after mutation of the catalytic residues glutamine 110 to alanine, DncV 
almost completely lost its enzymatic activity; when both aspartate 129 and aspartate 131 were 
mutated to alanine, DncV lost its enzymatic activity completely, which indicates the enzymatic 
activity of DncV is partially dependent on glutamine 110, and absolutely dependent on aspartic 
acid 129 in combination with aspartic acid 131. Cumulatively, these results further demonstrate 
that DncV synthesizes 3’3’-cGAMP and regulates biofilm formation and motility in E. coli 
ECOR31.
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4.3 PAPER III: A SINGLE AMINO ACID SUBSTITUTION IN CAPV LEADS TO 
PRONOUNCED CELL FILAMENTATION IN ESCHERICHIA COLI 
In the E. coli ECOR31 genome, dncV is flanked by the V. cholerae VSP-1 homologs of capV 
upstream and vc0180 and vc0181 downstream (126, 130) (Figure 8, paper II). In this paper, we 
characterized CapVQ329R, a variant of the patatin-like phospholipase CapV of strain ECOR31, 
demonstrating that its expression from a plasmid induces pronounced cell filamentation, 
repressed apparent swimming motility and flagella expression and rdar biofilm formation. This 
effect was not only observed in E. coli MG1655, but also in other E. coli commensal and 
clinical isolates as well as S. typhimurium UMR1, showing that induction of this morphological 
and physiological phenomenon is not only restricted to a single strain. 
In V. cholerae, CapV, which encodes a patatin-like phospholipase A (PNPLA), was identified 
as a cGAMP receptor that results in growth retardation upon activation (131). Bioinformatic 
analysis showed that CapV_ECOR31, which shows 65% amino acid sequence identity 
compared to CapV_V.cholerae, also contains a canonical PNPLA domain with the three main 
characteristic conserved signature motifs (160), the phosphate or anion binding motif G-G-G-
x-[K/R]-G, the esterase box G-x-S-x-G, and D-G-[A/G], a part of the catalytic dyad. Blast 
homology search of CapV_ECOR31 demonstrated that CapV_ECOR31 homologs with >60% 
identity is not only found in E. coli and V. cholerae strains, but also in many other bacterial 
species. Phylogenetic analysis of representative CapV_ECOR31 homologs supported 
classification into four different subgroups.  
Surprisingly, overexpression of CapV did not affect cell growth in E. coli MG1655, while a 
variant of CapV_ECOR31, CapVQ329R, induced a mild cell growth arrest after 7 h as estimated 
by the optical density (OD) of the cell suspension. Since the enzymatic activity of 
CapV_V.cholerae is activated by 3’3’-cGAMP which E. coli MG1655 does not possess, the 
results suggest that the CapVQ329R induced apparent arrest of cell growth may occur via a 
different mechanism, rather than by activation of CapV by the 3’3’-cGAMP signaling pathway 
and subsequent cell lysis.  
For rod-shaped cells, filamentation is a dramatic morphology adaptation under various stressful 
growth conditions. After exposure to stress, cell filamentation often occurs upon activation of 
the SOS response system and expression of the cell division inhibitor SulA, resulting in a cell 
division block (197-199). Surprisingly, we found that CapVQ329R induced extensive sulA-
independent cell filamentation upon overexpression in E. coli MG1655, while CapV wild type 
had only a minor effect. CapVQ329R-induced cell filamentation was initiated 2 h after the 
initiation of CapVQ329R expression, and continuous filament elongation was observed for 
around 6 h, while cells returned to rod-shape after 22 h. Indeed, follow-up experiments showed 
that the observed cell filamentation phenotype is dependent on the L-arabinose concentration 
and subsequently the CapVQ329R expression level. Moreover, results from mutation analyses 
indicate that the G-G-G-x-[K/R]-G and D-G-[AG] motifs, but not the G-x-S-x-G motif in the 
canonical PNPLA domain are required for CapVQ329R functionality. We further showed that, 
under our experimental conditions, CapVQ329R did hardly affect the viability of MG1655 cells. 
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Since the in vivo 3’3’-cGAMP signal was under the detection limit (data not shown), we 
assumed that the CapVQ329R-induced OD retardation suggesting an apparent cell growth arrest 
might be due to the pronounced cell filamentation. This hypothesis is in line with the viability 
counts. Alignment of the amino acid sequences of CapV homologues extracted by Blast 
homology search showed that Q329 is highly conserved among the CapV proteins. The 
position of Q329 is located outside of the putative PNPLA domain of CapV_ECOR31 and 
consequently not part of the characteristic motifs required for the catalytic activity of this 
phospholipase A2 (PLA2) superfamily member (159, 160). 3D model construction using the 
closest homolog of CapV_ECOR31 in the PDB database (FabD from Solanum cardiophyllum, 
PDB: 1oxwC) revealed that Q329_CapV is located in the context of the RARGRR329 sequence 
within the third last α helix with the arginine side chain pointing outwards causing no change 
in the overall structure of CapV_ECOR31. However, the switch from a potential hydrogen-
bond acceptor (Q) to a hydrogen-bond donor (R) with a longer side chain indicates that the 
CapV_ECOR31 mutant might shows altered enzymatic activity, ligand binding properties or 
protein-protein interactions. Furthermore, Arginine with its positively charged side chain is 
involved in a variety of different functionalities such as in binding of negative charged 
molecules such as phosphates present, for example, in DNA molecules or nucleotides and the 
RR twin arginine motif is part of the N-terminal signal sequence for the Twin-Arginine 
Translocation (TAt) pathway (200, 201). Furthermore, a RxxR motif constitutes a conserved 
peptidase cleavage site, while an RxxxR motif is part of the binding motif for c-di-GMP in PilZ 
domain proteins, whereby Arginine residues can bind O-6 and N-7 at the Hoogsteen edge of 
the guanine base (202). 
Filamentation induced by CapVQ329R is regulated by environmental conditions. We found that 
the CapVQ329R overexpression cells are less filamentous in LB medium than in TB medium. 
Supplementation with pyridoxine (vitamin B6) at 5 mg/ml in TB dramatically restricted 
CapVQ329R-induced cell filamentation, while supplementation with other B vitamins had no 
effect. CapVQ329R also inhibited swimming motility of MG1655 in the soft agar plate. 
Microscopic observation showed that the highly filamentous cells induced by CapVQ329R with 
more than 20 times the length did not show any movement, while shorter filaments were still 
motile, indicating that cells might gradually loose flagella and become non-motile upon 
CapVQ329R overexpression. 
Interestingly, expression of CapVQ329R also modulated rdar biofilm formation in E. coli strains. 
In the UPEC strain E. coli No.12 and other E. coli strains, CapVQ329R expression is 
accompanied by downregulation of the expression of the transcriptional regulator CsgD and 
the levels of the ubiquitous second messenger c-di-GMP. Besides c-di-GMP, the level of 
cAMP and 3’3’-cGAMP, both of which were reported to participate in biofilm regulation (130, 
203), was also altered. In UPEC, the cAMP-CRP complex regulates curli and cellulose 
production and the formation of rugose and pellicle biofilms through activation of csgD 
expression (203). In Paper II, we demonstrated that DncV synthesized 3’3’-cGAMP and 
participated in regulation of rdar biofilm formation in E. coli ECOR31 (130). Besides DncV, 
Hypr GGDEF domain containing proteins can also produce 3’3’-cGAMP (133, 135), 
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indicating Hypr GGDEF domain proteins might be directly or indirectly activated by 
CapVQ329R to produce 3’3’-cGAMP, and thus inhibit rdar biofilm formation of E. coli No.12. 
Moreover in M. xanthus, cAMP is an activator of the Hypr GGDEF enzyme GacB to produce 
3’3’-cGAMP, whereas GacB is inhibited directly by c-di-GMP (158), providing evidence for 
cross regulation between different cDNs signaling pathways.  
We also found that CapVQ329R induced cell filamentation without affecting cell arrangement of 
E. coli No.12 upon agar plate growth. The length of the filamentous cells on the agar plate is 
extended compared to TB medium suggesting that surface sensing or another environmental 
parameter associated with agar plate growth induced extended elongation. The CapVQ329R 
induced cell filamentation, swimming motility and rdar biofilm repression was not restricted 
to E. coli MG1655 and No.12, but also common to other E. coli strains and even S. 
typhimurium UMR1, suggesting a general role of CapVQ329R on various aspects of bacterial 
physiology.
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4.4 PAPER IV: ALTERNATIONS OF C-DI-GMP TURNOVER PROTEINS 
MODULATE SEMI-CONSTITUTIVE RDAR BIOFILM FORMATION IN 
COMMENSAL AND UROPATHOGENIC ESCHERICHIA COLI 
The expression of the rdar morphotype varies among different E. coli strains. For example, 
while certain pathogenic E. coli strains frequently express a typical rdar morphotype 
(expression at 28°C only), some commensal, but also UPEC E. coli strains express a semi-
constitutive rdar morphotype (expression at both 28°C and 37°C at a higher level) (127, 191, 
192). In this paper, we aimed to investigate the underlying molecular mechanism of semi-
constitutive rdar biofilm formation in three commensal E. coli strains, Tob1, Fec67, and Fec101, 
and four UPEC isolates, No.12, B-11870, 80//6, and B-8638. As a reference, we used the 
human commensal strain E. coli Fec10, a close homolog of E. coli K-12, which expresses a 
temperature-dependent rdar morphotype. 
The rdar morphotype is characterized by the expression of extracellular matrix components 
cellulose and curli fimbriae in E. coli (18). We found that all isolates expressed the rdar 
morphotype at both 28°C and 37°C, but showed variations in color intensity and roughness, 
suggesting variable ratio of cellulose versus curli fimbriae expression and variability in 
expression of the master transcriptional regulator CsgD.  CsgD expression accompanied rdar 
morphotype expression for all the strains at 28°C and 37°C, however, limited CsgD expression 
at 37°C was observed for Fec67 and 80//6. This is consistent with the previous finding that the 
rdar morphotype is independent on CsgD in the probiotic strain E. coli Nissle 1917 (204). 
However, a deletion mutant for csgD has to be constructed to confirm this hypothesis. Besides, 
cell aggregation and swimming motility also varied among the strains. While strains Fec101, 
B-11870, 80//6 showed strong adherence to glass (ring formation) and clumping, other strains 
did not display this phenotype. Only Tob1 showed a pronounced swimming motility, other 
strains were either nonmotile or much restricted in swimming motility compared to Tob1. 
Collectively, these results demonstrated that the level of rdar biofilm morphotype expression 
on Congo Red agar plate and biofilm formation in liquid culture cannot be directly correlated 
as previously observed (191, 205). Alternative extracellular matrix components other than curli 
fimbriae and cellulose can contribute to biofilm formation in liquid culture.  
In paper I, the genomes of commensal and pathogenic semi-constitutive rdar biofilm forming 
E. coli isolates were sequenced. E. coli has previously been phylogenetically classified into 7 
phylogroups (206). Genomic analysis indicated that strain Fec101 belongs to phylogroup B1, 
UPEC strain B-8638 to group D, and the remaining strains to group B2. Rdar morphotype 
expression and regulation in E. coli is characterized by distinct gene modules. Bioinformatic 
analysis found that the semi-constitutive E. coli isolates differ in their genomic content leading 
to rdar biofilm formation. The genomes of commensal strains Tob1, Fec101, and UPEC B-
8638 lack the pga operon, which encodes the biosynthesis gene products for poly-β-1,6-N-
acetyl-D-glucosamine (PNAG), a linear exopolysaccharide homopolymer that serves as an 
adhesin for the maintenance of the structural stability of biofilms in diverse eubacteria (207). 
In contrast, the pga operon is present in the commensal strain Fec67 and UPEC strain B-11870, 
80//6, and No.12, but in a different genomic context compared to E. coli K-12. The biosynthesis 
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operons for curli (csgBAC and csgDEFG operons (189, 208)) and cellulose (bcsABZC and 
bcsEFG operons (13, 209)) are present in all strains.  
The ubiquitous second messenger c-di-GMP is the key regulator of rdar biofilm formation in 
Enterobacteriaceae, in particular in Escherichia and Salmonella spp. (2, 18). The complex c-
di-GMP signaling network involves numerous c-di-GMP turnover proteins, e.g. DGCs and 
PDEs. We also observed a high variability in the number of c-di-GMP turnover proteins in the 
genomes of the semi-constitutive E. coli strains using E. coli K-12 strain MG1655 and E. coli 
Fec10 as a reference (63). Specifically, the DGCs YcdT, and YddV/DosC are not present in 
three (Tob1, Fec101, B-8638) and four (Tob1, Fec67, B-11870, No.12) strains, respectively, 
while other conserved core reference c-di-GMP turnover proteins including AdrA, YliF, Rtn, 
YhjH, YhjK, YlaB, YhdA, YeaI are present but show substantial amino acid variations in all 
strains. Moreover, stop codons and frameshift mutations are found within several open reading 
frames (ORFs), indicating potentially nonfunctional truncated proteins. Interestingly, several 
c-di-GMP turnover proteins not present in E. coli K-12 (63) are also found in several strains, 
including the GGDEF protein DgcX (UniProt B7LBD9_ECO55) in Fec101, the EAL protein 
PdeX (UniProt Q707K1_ECOLX) in Tob1, and PdeY (UniProt Q1RDG4_ECOUT) in No.12, 
B-11870 and Fec67. In addition, three novel EAL domain proteins were identified in UPEC 
strains, namely PdeU1 in B-11870 and 80//6, PdeU2 in B-11870, and PdeU3 in B-8638. 
Previous studies indicated that c-di-GMP turnover proteins can potentially contribute to the 
semi-constitutive rdar morphotype. For example, the E. coli probiotic strain Nissle 1917 and 
commensal strain 1094 show CsgD and DGC AdrA independent cellulose expression (204, 
210).  
In E. coli, YciR has been identified as a trigger enzyme that, besides possessing dual catalytic 
function, controls csgD transcription and thus affect rdar biofilm formation through protein-
protein interactions (67, 68, 211). Bioinformatic analysis showed that YciR contains a tandem 
PAS-GGDEF-EAL domain, and distinct amino acid substitutions are found in all semi-
constitutive rdar strains compared to YciR from E. coli K-12 and Fec10. In strain B-11870, a 
nonsense mutation resulted in the insertion of a stop codon into the EAL domain, which leads 
to the truncated PAS-GGDEF YciRB-11870 protein. Overexpression of YciR from Fec10 and 
Fec101 dramatically downregulated the rdar morphotype of Tob1 at both temperatures 
concomitant with downregulation of CsgD expression, whereas YciR from Tob1 only 
decreased the rdar morphotype moderately. Overexpression of YciR from B-11870 
predominantly upregulated the rdar morphotype and CsgD expression at 28°C, while 
overexpression of YciR (YciRB-11870_Full) with the reversion of the stop codon into a sense 
codon resulted in decreased rdar morphotype at both temperatures.  
Of note, YciR from E. coli Tob1 contains eleven amino acid substitutions compared to YciR 
from Fec10 and exhibits substantially altered activity. Results from the site-directed mutants 
demonstrate that T37I, T371A, and combined T37I/T371A mutants of YciR from Fec10 
resembled the protein activity of YciR from Tob1 on rdar morphotype of Tob1 at 28°C, while 
YciR variants T37I, A90G, A361S and T371A closely resembled YciR from Tob1 at 37°C. 
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Other mutants are either failed to assemble or showed inconsistent phenotype. Similarly, the 
same result was observed when mutant YciRT37I, YciRT371A, and combined YciRT37I/T371A 
derived from Fec101 was introduced into Tob1. In conclusion, T37I is the most determinative 
amino acid exchange in combination with T371A. Of note, T37 and T371 of YciR are located 
outside of the catalytic motifs and on GGEDF motif, suggesting that these amino acid 
substitutions probably affect protein–protein interactions. In addition, mutations in the 
consensus catalytic motifs in YciR from Fec101 and YciR from Tob1 consistently showed that 
the E440AL mutant of YciR from Fec101 and YciR from Tob1 downregulated the rdar 
morphotype of Tob1 more effectively than the respective wild type proteins, while the 
GGD316E317F mutant of YciR from Fec101 and YciR from Tob1 resulted in a colony with 
increased roughness and increased fluorescence under UV light compared to the wild type 
protein, suggesting enhanced cellulose production. 
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5 CONCLUDING REMARKS AND PERSPECTIVES 
In this thesis, we characterized the networks of metabolizing proteins for the second 
messengers c-di-GMP and 3’3’-cGAMP in E. coli with respect to the regulation of 
multicellular behavior such as semi-constitutive rdar biofilm formation and swimming motility 
(Paper I, Paper II, Paper III, Paper IV) as well as regulation of cell morphology (Paper III). 
3’3’-cGAMP is novel cyclic dinucleotide second messenger that regulates many aspects of 
bacterial physiology. We demonstrated that DncV synthesized 3’3’-cGAMP and regulates 
biofilm formation and flagella biosynthesis in the animal commensal strain E. coli ECOR31 
(Paper I). However, the 3’3’-cGAMP turnover proteins, PDEs and GACs as well as 
receptors/effectors involved in these phenotypes are still not identified. Whether 3’3’-cGAMP 
is involved in the regulation of alternative bacterial phenotypes also need to be further 
investigated.  
We also characterized the role of the patatin-like phospholipase CapV and its CapVQ329R 
variant in the regulation of phenotypes such as cell morphology (filamentation), biosynthesis 
of flagella and swimming motility and rdar biofilm formation and CsgD expression (Paper III). 
In vivo evidence suggests that CapV and CapVQ329R might exert as a patatin-like phospholipase 
as we observed a dramatic change in the content of charged phospholipids (unpublished data), 
however, further biochemical and structural studies need to be conducted to confirm this 
hypothesis and give insights into the detailed molecular mechanisms of the enzymatic 
functionality such as substrate specificity and regulation of the catalytic activity. It will also be 
interesting to further unravel the molecular basis of extended cell filamentation, and repression 
of biofilm formation and flagella biosynthesis and the overall physiological changes that occur 
upon expression of CapVQ329R.  
We also analyzed the genomes of seven semi-constitutive rdar biofilm forming E. coli strains 
and investigated the role of the c-di-GMP turnover and trigger protein YciR to regulate rdar 
biofilm formation and csgD expression (Paper I, Paper IV). Besides YciR, other c-di-GMP 
turnover proteins show distinct amino acid substitutions correlated with semi-constitutive rdar 
morphotype expression (unpublished data), however, whether and how these gene products 
contribute to the regulation of the temperature-independent expression of the rdar morphotype 
and biofilm components needs to be further tested. 
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